AstraZeneca Calquence plus chemoimmunotherapy approved in EU for 1st-line mantle cell lymphoma Ruchika Sharma7 May 2025 12:30 PM ISTCambridge: AstraZeneca has announced that Calquence (acalabrutinib) in combination with bendamustine and rituximab has been approved in the...
Study finds pinworm medication has potential to treat aggressive skin cancer Dr. Kamal Kant Kohli6 May 2025 9:45 AM ISTA common pinworm medication may stop and reverse cancer growth in Merkel cell carcinoma, an aggressive form of skin cancer, according to research led...
Zinc-transporting protein contributes to aggressive growth of brain tumor, OU researchers find Dr. Kamal Kant Kohli5 May 2025 9:00 PM ISTIn a study published Wednesday in the Proceedings of the National Academy of Sciences (PNAS), University of Oklahoma researchers detail their...
AI-Enabled X-Rays Help Detect Lung Cancer Risk in 50,000 Patients Worldwide: Study Shows Dr. Garima Soni5 May 2025 8:30 AM ISTAstraZeneca, in partnership with health-tech company Qure.ai, has successfully completed over 5 million artificial intelligence (AI)-enabled chest...
Mediterranean Diet Linked to Lower Breast Cancer Risk in Women, suggests study Dr Riya Dave5 May 2025 8:15 AM ISTResearchers have discovered in a new study that strict adherence to the Mediterranean diet significantly reduces the risk of breast cancer in women,...
Too Much Chicken? New Study Links High Chicken Consumption to Increased Risk of Early Death Dr. Garima Soni5 May 2025 8:00 AM ISTA recent study published in the journal Nutrients suggests that high poultry consumption may be linked to an increased risk of death from...
Research alert: High cannabis use linked to increased mortality in colon cancer patients Dr. Kamal Kant Kohli4 May 2025 8:30 PM ISTResearchers at the University of California San Diego School of Medicine have found that individuals with colon cancer and a documented history of...
EMA Committee recommends EU label update for Roche Phesgo to allow administration outside of clinical settings Ruchika Sharma4 May 2025 1:30 PM ISTBasel: Roche has announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive...
Bayer begins Phase I study targeting GPC3 with alpha radiopharmaceutical in advanced hepatocellular carcinoma patients Ruchika Sharma4 May 2025 12:30 PM ISTBerlin: Bayer has announced the initiation of a Phase I clinical trial with 225Ac-GPC3 (BAY 3547926), an investigational targeted alpha...
Non-risk-based lung cancer screening with low-dose computed tomography: JAMA Dr. Kamal Kant Kohli3 May 2025 7:00 AM ISTIn 2015, the First Affiliated Hospital of Guangzhou Medical University, in collaboration with the Guangdong Hetaoxiang Medical Charity Foundation and...
Gut microbes release cancer-fighting bile acids that block hormone signals, suggests research Dr. Kamal Kant Kohli2 May 2025 8:15 PM ISTBacteria naturally present in the human intestine (known as the gut microbiota) can transform cholesterol-derived bile acids into powerful metabolites...
New drug shows promise in treating liver disease caused by metabolic dysfunction, cancer: Study Dr. Kamal Kant Kohli1 May 2025 8:45 PM ISTA study published in Nature Aging has revealed a promising new drug candidate that may help combat metabolic dysfunction-associated steatotic liver...
